✦ LIBER ✦

ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma

✍ Scribed by Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán; María de Jesús Nambo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab-ESHAP as a mobilization regime

✍ Min Kyoung Kim; Shin Kim; Sung Sook Lee; Sun Jin Sym; Dae Ho Lee; Sang We Kim; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 163 KB

R-ESHAP plus pegfilgrastim as an effecti

✍ Montoro, Juan; Andreola, Giovanna; Gardellini, Angelo; Babic, Aleksandra; Negri, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Bendamustine combined with rituximab for

✍ Vacirca, Jeffrey L.; Acs, Peter. I.; Tabbara, Imad A.; Rosen, Peter. J.; Lee, Pe 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 339 KB

Efficacy and Safety of Rituximab Combine

✍ Harting, Rekha; Venugopal, Parameswaran; Gregory, Stephanie A.; O'Brien, Teresa; 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 168 KB

Rituximab and CHOP for elderly patients

✍ Carol S. Portlock 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 116 KB

ESHAP+fixed dose G-CSF as autologous per

✍ Akhtar, S; Tbakhi, A; Humaidan, H; El Weshi, A; Rahal, M; Maghfoor, I 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB